Abstract
Background
Despite the high use of antidepressants (ADs) among the elderly, there is limited information about the prescribing pattern of these drugs in the Italian elderly population. The aim of this study was to analyze the trend in the use of ADs in the Italian elderly patients in the years 2003-2009, and specifically, to evaluate rates and predictors of AD treatment discontinuation in depressed older patients.
Methods
The nationwide general practice Health Search Database (HSD) was used to identify AD users aged 65 years old and over from 2003 to 2009. ADs were categorized as (1) selective serotonin reuptake inhibitors (SSRIs); (2) serotonin-norepinephrine reuptake inhibitors (SNRIs); (3) tricyclic antidepressants (TCAs); (4) noradrenergic and specific serotonergic antidepressants (NaSSAs); and (5) other ADs. Incidence and prevalence of AD use per 1,000 inhabitants was calculated by drug class and single compound. We also measured rates and predictors of AD discontinuation (i.e., treatment gap ≥ 60 days) during the first year of therapy.
Results
Overall, 39,557 AD users ≥65 years (17 % of the total HSD elderly population) were included in the study. SSRIs were increasingly and most frequently prescribed ADs (102.7-195.3 per 1,000 over seven years). The most common indications for AD use were depression and anxiety. Overall, 14 % of AD users continued their AD medication without treatment gaps, 27 % were intermittent AD users and 58 % discontinued their ADs during the first year of follow-up. Specific AD classes such as TCAs and ‘other ADs were found to be predictors of discontinuation. In depressed patients, the use of NaSSas, TCAs and ‘other ADs as well the concomitant use of >5 drugs (other than ADs) and living in Southern Italy were more likely to predict discontinuation.
Conclusion
ADs, especially SSRIs, are widely and increasingly prescribed in elderly Italian patients in recent years. The observed high AD discontinuation rates are likely to impact the achievement of a therapeutic endpoint in depressed patients. Patients who are at high risk of AD discontinuation such as those receiving multi-drug therapy or living in Southern Italy should be monitored more closely to improve benefits of AD treatments.
Similar content being viewed by others
References
Unutzer J (2007) Clinical practice. Late-life depression. N Engl J Med 357(22):2269–2276
Castro-Costa E, Dewey M, Stewart R, Banerjee S, Huppert F, Mendonca-Lima C et al (2007) Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study. Br J Psychiatry 191:393–401
Ereshefsky L, Saragoussi D, Despiegel N, Hansen K, Francois C, Maman K (2010) The 6-month persistence on SSRIs and associated economic burden. J Med Econ 13(3):527–536
Trifiro G, Tillati S, Spina E, Ferrajolo C, Alacqua M, Aguglia E et al (2013) A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur J Clin Pharmacol 69(2):227–236
Mann JJ (2005) The medical management of depression. N Engl J Med 353(17):1819–1834
Trifiro G, Barbui C, Spina E, Moretti S, Tari M, Alacqua M et al (2007) Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 16(5):552–559
Berardi D, Menchetti M, De Ronchi D, Rucci P, Leggieri G, Ferrari G (2002) Late-life depression in primary care: a nationwide Italian epidemiological survey. J Am Geriatr Soc 50(1):77–83
Berardi D, Leggieri G, Ceroni GB, Rucci P, Pezzoli A, Paltrinieri E et al (2002) Depression in primary care. A nationwide epidemiological survey. Fam Pract 19(4):397–400
Parabiaghi A, Franchi C, Tettamanti M, Barbato A, D’Avanzo B, Fortino I et al (2011) Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness. Eur J Clin Pharmacol 67(10):1077–1083
Balestrieri M, Carta MG, Leonetti S, Sebastiani G, Starace F, Bellantuono C (2004) Recognition of depression and appropriateness of antidepressant treatment in Italian primary care. Soc Psychiatry Psychiatr Epidemiol 39(3):171–176
Marengoni, A., Bianchi, G., Nobili, A., Tettamanti, M., Pasina, L., Corrao, S. et al., Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients. Int Psychogeriatr: p. 1-8
Kuyken W, Byford S, Byng R, Dalgleish T, Lewis G, Taylor R et al (2012) Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial. Trials 11:99
National Institute for Health & Clinical Excellence (2010) Depression: The Treatment and Management of Depression in Adults (Updated Edition)
World Health Organisation. Duration of antidepressant treatment. 2012 [cited 16.12.13]; Available from: http://www.who.int/mental_health/mhgap/evidence/depression/q2/en/index.html.
Lapi F, Simonetti M, Michieli R, Pasqua A, Brandi ML, Frediani B et al (2012) Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone 50(1):85–90
Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R et al (2003) Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 25(3):254–257
Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V et al (2009) Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 120(16):1598–1605
Trifiro G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M et al (2012) Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 72(5):694–700
Melfi C, Holleman E, Arthur D (1995) Katz B Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data. J Clin Epidemiol 48(7):917–926
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
Aguglia E, Ravasio R, Simonetti M, Pecchioli S, Mazzoleni F (2012) Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003-2009. Curr Med Res Opin 28(9):1475–1484
StataCorp (1999) Stata Statistical Software
Poluzzi E, Motola D, Silvani C, De Ponti F, Vaccheri A, Montanaro N (2004) Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. Eur J Clin Pharmacol 59(11):825–831
Percudani M, Barbui C, Fortino I, Petrovich L (2004) Antidepressant drug use in Lombardy, Italy: a population-based study. J Affect Disord 83(2–3):169–175
Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K et al (2008) Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 23(1):66–73
Spina E, Trifiro G, Caraci F (2012) Clinically significant drug interactions with newer antidepressants. CNS Drugs 26(1):39–67
Trifiro G, Dieleman J, Sen EF, Gambassi G, Sturkenboom MC (2010) Risk of ischemic stroke associated with antidepressant drug use in elderly persons. J Clin Psychopharmacol 30(3):252–258
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R et al (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373(9665):746–758
Ferguson JM (2001) SSRI Antidepressant Medications: Adverse Effects and Tolerability. Prim Care Companion J Clin Psychiatry 3(1):22–27
FDA, FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses (2013) FDA: Maryland
FDA, FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide) (2012)
Dolder CR, Nelson MH, Iler CA (2012) The effects of mirtazapine on sleep in patients with major depressive disorder. Ann Clin Psychiatry 24(3):215–224
Pfizer, GD-mirtazapine OD Monograph (2012)
Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R et al (2011) Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 378(9789):403–411
Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA (2004) Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 60(1):57–61
Olfson M, Marcus SC, Tedeschi M, Wan GJ (2006) Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 163(1):101–108
Mounsey AL, Matthew LG, Slawson DC (2005) Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician 72(6):1075–1080
Conflict of interest
All authors have no conflicts of interests to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sultana, J., Italiano, D., Spina, E. et al. Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study. Eur J Clin Pharmacol 70, 469–478 (2014). https://doi.org/10.1007/s00228-013-1636-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-013-1636-z